Efficacy and safety of artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated Plasmodium falciparum malaria in Liberia, 2022–2023
Victor S. Koko(University of Liberia), Jonathan Schultz(Centers for Disease Control and Prevention), Wahdae-mai Harmon-Gray, Jessica Kafuko(U.S. President's Malaria Initiative), Uwem Inyang(United States Agency for International Development), Mateusz M. Pluciński(Centers for Disease Control and Prevention), Jethro Zawolo(University of Liberia), Zhiyong Zhou(China Three Gorges University), Mamadou O. Diallo(Centers for Disease Control and Prevention), Trokon Washington, Veronika R. Laird(Oak Ridge Associated Universities), Odell Kumeh, Laura Skrip(London School of Hygiene & Tropical Medicine)
Cited by 2
Related Papers
A review and agenda for integrated disease models including social and behavioural factors
|Nature Human Behaviour|2021|227
Persisting Viral Sequences Shape Microbial CRISPR-based Immunity
|PLoS Computational Biology|2012|151
Community engagement in outbreak response: lessons from the 2014–2016 Ebola outbreak in Sierra Leone
|BMJ Global Health|2020|102
Effect of Ebola Progression on Transmission and Control in Liberia
|Annals of Internal Medicine|2014|93
Quantifying Poverty as a Driver of Ebola Transmission
|PLoS neglected tropical diseases|2015|85